US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 0.917
  • -0.113-11.01%
Close Nov 21 16:00 ET
  • 0.920
  • +0.003+0.37%
Post 20:01 ET
255.93MMarket Cap-1160P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyell Immunopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q334.000K / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q334.000K / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Lyell Immunopharma Earnings Reports

  • Lyell Immunopharma | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:26

  • Lyell Immunopharma | 10-Q: Q2 2024 Earnings Report

    Aug 8 10:19

  • Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

    Aug 8 04:13

  • Lyell Immunopharma | 10-Q: Q1 2024 Earnings Report

    May 6 20:09

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data